Since CAFs induce the expression of aromatase, which converts androgens to estrogens in lung cancer cells [66], androgen levels in lung cancer tissues may be maintained at low levels, and testosterone may have a weaker effect on CAFs than on estrogen. Here, CYP19A1 is linked to lung carcinoma.